BIOMAT Database Logo BIOMAT Database Logo

Streptozotocin (NSC-85998) in the treatment of lymphoreticular malignancies. 1975

M J O'Connell, and P H Wiernik

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M J O'Connell, and P H Wiernik
Nephrotoxicity of streptozotocin (NSC-85998).
December 1970, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Tissue distribution of streptozotocin (NSC-85998).
January 1974, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Renal tumorigenic action of streptozotocin (NSC-85998) in rats.
September 1968, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Metastatic renal adenocarcinoma produced by streptozotocin (NSC-85998).
January 1975, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Antileukemic activity of streptozotocin (NSC-85998) and its analogs.
December 1972, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Fate of streptozotocin (NSC-85998)in patients with advanced cancer.
January 1975, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Toxicologic evaluation of streptozotocin (NSC 85998) in mice, dogs and monkeys.
January 1980, Drug and chemical toxicology,
M J O'Connell, and P H Wiernik
Streptozotocin (NSC-85998) in children with acute lymphocytic leukemia. A Southwest Oncology Group study.
July 1979, Journal of clinical pharmacology,
M J O'Connell, and P H Wiernik
Urinary excretion of beta-glucuronidase after administration of streptozotocin (NSC-85998) to Fischer rats.
April 1973, Cancer chemotherapy reports,
M J O'Connell, and P H Wiernik
Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.
January 1975, Cancer chemotherapy reports,
Copied contents to your clipboard!